Holen Sie sich die Stockscreener-App
131.72
1.75%
-2.325
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CHRW?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$134.04
Offen:
$133.56
24-Stunden-Volumen:
490.34K
Relative Volume:
0.32
Marktkapitalisierung:
$15.56B
Einnahmen:
$17.36B
Nettoeinkommen (Verlust:
$508.09M
KGV:
31.51
EPS:
4.18
Netto-Cashflow:
$581.04M
1W Leistung:
-2.29%
1M Leistung:
+4.47%
6M Leistung:
+43.23%
1J Leistung:
+21.64%
1-Tages-Spanne:
$131.26
$133.70
1-Wochen-Bereich:
$130.55
$137.77
52-Wochen-Spanne:
$84.68
$138.00
C H Robinson Worldwide Inc Stock (CHRW) Company Profile
Firmenname
C H Robinson Worldwide Inc
Sektor
Telefon
(952) 937-8500
Adresse
14701 CHARLSON ROAD, EDEN PRAIRIE, MN
Vergleichen Sie CHRW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CHRW
C H Robinson Worldwide Inc
|
131.77 | 15.83B | 17.36B | 508.09M | 581.04M | 4.18 |
|
UPS
United Parcel Service Inc
|
85.50 | 73.10B | 90.16B | 5.73B | 3.54B | 6.7265 |
|
FDX
Fedex Corp
|
237.64 | 56.61B | 88.59B | 4.12B | 3.65B | 17.11 |
|
EXPD
Expeditors International Of Washington Inc
|
117.81 | 16.39B | 11.27B | 854.10M | 810.15M | 6.1285 |
|
JBHT
J B Hunt Transport Services Inc
|
144.83 | 14.19B | 12.06B | 561.13M | 513.08M | 5.51 |
C H Robinson Worldwide Inc Stock (CHRW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-10-01 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-07-31 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-07-31 | Bestätigt | TD Cowen | Hold |
| 2025-07-01 | Fortgesetzt | Robert W. Baird | Neutral |
| 2025-07-01 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-05-01 | Bestätigt | TD Cowen | Hold |
| 2025-03-13 | Eingeleitet | Truist | Buy |
| 2025-03-07 | Eingeleitet | Deutsche Bank | Buy |
| 2025-01-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-01-10 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-01-03 | Hochstufung | Susquehanna | Neutral → Positive |
| 2024-12-13 | Bestätigt | TD Cowen | Hold |
| 2024-12-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-11-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-31 | Bestätigt | TD Cowen | Hold |
| 2024-10-09 | Eingeleitet | Citigroup | Neutral |
| 2024-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2024-08-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-08-01 | Bestätigt | TD Cowen | Hold |
| 2024-07-22 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-07-09 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-07-09 | Hochstufung | Vertical Research | Sell → Buy |
| 2024-06-25 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-06-07 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-06 | Hochstufung | UBS | Sell → Neutral |
| 2024-05-15 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-05-02 | Bestätigt | TD Cowen | Hold |
| 2024-04-11 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2024-04-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-03-27 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-01-10 | Hochstufung | Susquehanna | Negative → Neutral |
| 2023-08-31 | Herabstufung | Susquehanna | Neutral → Negative |
| 2023-02-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-02-03 | Herabstufung | Stifel | Buy → Hold |
| 2023-01-17 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-01-10 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | Cowen | Outperform → Market Perform |
| 2023-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-04 | Herabstufung | UBS | Neutral → Sell |
| 2022-11-30 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2022-11-15 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2022-10-25 | Eingeleitet | Jefferies | Hold |
| 2022-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-17 | Herabstufung | Vertical Research | Hold → Sell |
| 2022-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-06-28 | Eingeleitet | Credit Suisse | Underperform |
| 2022-04-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-03-02 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-02-03 | Bestätigt | Barclays | Equal Weight |
| 2022-02-03 | Bestätigt | Citigroup | Buy |
| 2022-02-03 | Bestätigt | Cowen | Outperform |
| 2022-02-03 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-03 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Bestätigt | Wolfe Research | Outperform |
| 2022-01-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-01-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-01-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-01-03 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-10-11 | Hochstufung | Vertical Research | Hold → Buy |
| 2021-09-13 | Eingeleitet | Evercore ISI | In-line |
| 2021-06-07 | Hochstufung | Goldman | Sell → Buy |
| 2021-03-26 | Fortgesetzt | Vertical Research | Hold |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2020-11-20 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-10-29 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-09-24 | Eingeleitet | Wells Fargo | Underweight |
| 2020-08-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-07-30 | Herabstufung | Loop Capital | Buy → Hold |
| 2020-07-30 | Herabstufung | Stifel | Buy → Hold |
| 2020-07-07 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-06-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2020-04-30 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-06 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2020-04-01 | Hochstufung | UBS | Neutral → Buy |
| 2020-01-30 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-01-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-15 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-01-07 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-11-01 | Herabstufung | Goldman | Neutral → Sell |
| 2019-10-30 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-10-30 | Bestätigt | Cowen | Outperform |
| 2019-07-26 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
C H Robinson Worldwide Inc Aktie (CHRW) Neueste Nachrichten
Uber Freight, RXO, C.H. Robinson headline 3PL/logistics track at 2025 NextGen… - Supply Chain Management Review
Loop Capital Adjusts Price Target on C.H. Robinson Worldwide to $133 From $124, Maintains Hold Rating - MarketScreener
Why C.H. Robinson Worldwide Inc. (CH1A) stock is a strong analyst pickEarnings Recap Summary & Consistent Return Investment Signals - newser.com
C.H. Robinson’s SWOT analysis: tech-driven growth fuels stock’s potential By Investing.com - Investing.com Nigeria
C.H. Robinson (CHRW) Faces Valuation Challenges Amid AI-Driven E - GuruFocus
Citi turns bullish on ArcBest, cuts outlook on C.H. Robinson on valuation concerns (ARCB:NASDAQ) - Seeking Alpha
C.H. Robinson’s SWOT analysis: tech-driven growth fuels stock’s potential - Investing.com
C.H. Robinson Worldwide (CHRW): Citigroup Downgrades Rating, Rai - GuruFocus
Implied Volatility Surging for C.H. Robinson Worldwide Stock Options - Nasdaq
Goldman Sachs Adjusts Price Target on C.H. Robinson Worldwide to $117 From $112, Maintains Neutral Rating - MarketScreener
JPMorgan Adjusts PT on C.H. Robinson Worldwide to $155 From $126, Maintains Overweight Rating - MarketScreener
Citigroup Downgrades C.H. Robinson Worldwide to Neutral From Buy, Adjusts PT to $148 From $134 - MarketScreener
Wolfe Research Adjusts C.H. Robinson Worldwide Price Target to $161 From $149 - MarketScreener
BMO Capital Adjusts Price Target on C.H. Robinson Worldwide to $135 From $110, Maintains Market Perform Rating - MarketScreener
C.H. Robinson Third Quarter 2025 Earnings Release and Conference Call Scheduled for Wednesday, October 29, 2025 - Yahoo Finance
3 Reasons to Sell CHRW and 1 Stock to Buy Instead - The Globe and Mail
Wells Fargo & Company Increases C.H. Robinson Worldwide (NASDAQ:CHRW) Price Target to $155.00 - MarketBeat
Stephens Adjusts C.H. Robinson Worldwide Price Target to $135 From $126, Maintains Equal Weight Rating - MarketScreener
Can you recover from losses in C.H. Robinson Worldwide Inc.Weekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Short interest data insights for C.H. Robinson Worldwide Inc.CEO Change & Free High Return Stock Watch Alerts - newser.com
C.H. Robinson Worldwide, Inc. $CHRW Shares Sold by Cullinan Associates Inc. - MarketBeat
How C.H. Robinson Worldwide Inc. stock benefits from tech adoptionJuly 2025 Weekly Recap & Weekly High Potential Alerts - newser.com
C.H. Robinson Worldwide, Inc. $CHRW Shares Sold by J. Safra Sarasin Holding AG - MarketBeat
What’s next for C.H. Robinson Worldwide Inc. stock price - newser.com
Analyzing drawdowns of C.H. Robinson Worldwide Inc. with statistical tools2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
Is CH Robinson Worldwide Inc a good long term investmentPrice Volatility Patterns & Free Short-Term Trading Strategies - earlytimes.in
Janney Montgomery Scott LLC Sells 14,277 Shares of C.H. Robinson Worldwide, Inc. $CHRW - MarketBeat
C.H. Robinson Worldwide Inc. stock retracement – recovery analysisWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
Will C.H. Robinson Worldwide Inc. stock go up soon2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
UBS Maintains 'Buy' Rating and Raises Price Target for C.H. Robi - GuruFocus
UBS Adjusts Price Target on C.H. Robinson Worldwide to $166 From $133, Maintains Buy Rating - MarketScreener
C.H. Robinson Worldwide (NASDAQ:CHRW) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
C.H. Robinson (CHRW) Valuation: Exploring Overvalued Versus Undervalued Perspectives After Recent Share Price Gains - Yahoo Finance
UBS Maintains C.H. Robinson Worldwide(CHRW.US) With Buy Rating, Raises Target Price to $166 - 富途牛牛
How C.H. Robinson Worldwide Inc. (CH1A) stock trades in high volatilityProfit Target & Daily Oversold Bounce Ideas - newser.com
Can C.H. Robinson Worldwide Inc. (CH1A) stock test all time highsMarket Movement Recap & AI Powered Market Entry Strategies - newser.com
How geopolitical risks impact C.H. Robinson Worldwide Inc. (CH1A) stock2025 Year in Review & Smart Allocation Stock Reports - newser.com
Lbp Am Sa Has $2.56 Million Holdings in C.H. Robinson Worldwide, Inc. $CHRW - MarketBeat
Will C.H. Robinson Worldwide Inc. stock benefit from AI adoption2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
Is C.H. Robinson Worldwide Inc. stock attractive for passive investorsQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Deutsche Bank Raises Price Target for C.H. Robinson Worldwide (C - GuruFocus
Precision Wealth Strategies LLC Purchases Shares of 3,824 C.H. Robinson Worldwide, Inc. $CHRW - MarketBeat
Barclays Upgrades C.H. Robinson Worldwide (CHRW) - Nasdaq
Deutsche Bank Adjusts Price Target on C.H. Robinson Worldwide to $159 From $124, Maintains Buy Rating - MarketScreener
C.H. Robinson Worldwide (NASDAQ:CHRW) Rating Increased to Equal Weight at Barclays - Defense World
Park-Ohio Holdings appoints former C.H. Robinson CFO to board By Investing.com - Investing.com Canada
Park-Ohio Holdings appoints former C.H. Robinson CFO to board - Investing.com
Supply Chain Leader ParkOhio Strengthens Board with Former C.H. Robinson CFO Andrew Clarke Appointment - Stock Titan
C.H. Robinson stock rating upgraded by Barclays on technology transformation - Investing.com Canada
Finanzdaten der C H Robinson Worldwide Inc-Aktie (CHRW)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):